BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14658127)

  • 1. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Malik V; Kupfer Y; Tessler S
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Brotman DJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Glynn RJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
    Crowther MA; Ginsberg JS; Julian J; Denburg J; Hirsh J; Douketis J; Laskin C; Fortin P; Anderson D; Kearon C; Clarke A; Geerts W; Forgie M; Green D; Costantini L; Yacura W; Wilson S; Gent M; Kovacs MJ
    N Engl J Med; 2003 Sep; 349(12):1133-8. PubMed ID: 13679527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Seneviratne C; Kupfer Y; Tessler S
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879892
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prophylaxis with warfarin for venous thromboembolism.
    Büller HR; Prins MH
    N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    van Dongen CJ; Prins MH; Büller HR
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12878749
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Krishnan JA; Streiff MB
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Aberegg SK
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879891
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Cosmi B; Palareti G
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879889
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 18. Venous thrombosis as a chronic disease.
    Schafer AI
    N Engl J Med; 1999 Mar; 340(12):955-6. PubMed ID: 10089190
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
    Kearon C; Ginsberg JS; Kovacs MJ; Anderson DR; Wells P; Julian JA; MacKinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M;
    N Engl J Med; 2003 Aug; 349(7):631-9. PubMed ID: 12917299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.